Real‐World Treatment Patterns and Progression‐Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non‐Small Cell Lung Cancer

Overview of attention for article published in Oncologist, July 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 6 X users

facebook: 1 Facebook page

Readers on

mendeley: 50 Mendeley

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 73,854 followers.

RT @OncJournal: Real‐World Treatment Patterns and Progression‐Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinas…

Real‐World Treatment Patterns and Progression‐Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non‐Small Cell Lung Cancer #ALK #TKI #lymphoma #NSCLC #rwPFS https://t.co/KxvM1nyRuE https://t.co/Fi…

Real‐world treatment patterns and progression‐free survival associated with anaplastic lymphoma kinase (ALK ) tyrosine kinase inhibitor therapies for ALK + #NSCLC: https://t.co/BGukg4xHyp

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.